Magali Lacroix‐Triki

Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy

Antonella Sistigu, Takahiro Yamazaki, Erika Vacchelli et al. · Nature Medicine · 2014 · 1K citations

Medicine, Cancer Biology, Oncology +12

Tumor-Infiltrating Lymphocytes and Prognosis: A Pooled Individual Patient Analysis of Early-Stage Triple-Negative Breast Cancers

Sherene Loi, Damien Drubay, Sylvia Adams et al. · Journal of Clinical Oncology · 2019 · 891 citations · Full text

Medicine, Biostatistics, Oncology +17

Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: a multicentre, prospective trial (SAFIR01/UNICANCER)

Fabrice André, Thomas Bachelot, Frédéric Commo et al. · The Lancet Oncology · 2014 · 405 citations

Medicine, Genetics, Oncology +16

Mutational Profile of Metastatic Breast Cancers: A Retrospective Analysis

Céline Lefèbvre, Thomas Bachelot, Thomas Filleron et al. · PLoS Medicine · 2016 · 405 citations · Full text

Medicine, Genetics, Oncology +17

β-Catenin pathway activation in breast cancer is associated with triple-negative phenotype but not with CTNNB1 mutation

Felipe C. Geyer, Magali Lacroix‐Triki, Kay Savage et al. · Modern Pathology · 2010 · 375 citations · Full text

Veterinary Medicine, Genetics, Oncology +14